Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Retinal supplementation augments optogenetic stimulation efficacy in vivo

Retinal supplementation augments optogenetic stimulation efficacy in vivo

Thumbnail Image
Download
Name

Srinivasan et al_2019_J._Neural_Eng._10.1088_1741-2552_ab1e22.pdf

Description
Accepted version
Size

1.09 MB

Format

Adobe PDF

Checksum (MD5)

d6d5dc7a143c821bd1eb2d7b19bb1a6b

sword-2019-07-22T18:03:52.original.xml (130 B)
Original SWORD entry document
Author(s)
Srinivasan, Shriya
•
Schelhaas, Booker
•
Maimon, Benjamin
•
Song, Hyungeun
•
Herr, Hugh
Date Issued
2019
Journal
Journal of Neural Engineering
Publisher
IOP Publishing
Version
Author's final manuscript
Abstract
© 2019 IOP Publishing Ltd. Objective. Over the last two decades, optical control of neuronal activity in the central nervous system has seen rapid development, demonstrating the utility of optogenetics as both an experimental and therapeutic tool. Conversely, applications of optogenetics in the peripheral nervous system have been relatively constrained by the challenges of temporally variable opsin expression, light penetration and immune attack of non-native opsins. Whilst opsin expression can be increased significantly through high-concentration viral induction, subsequent attack by the immune system causes temporal decay and high variability in electrophysiological response. Approach. In this study, we present a method to circumvent the aforementioned challenges by locally supplementing all-trans-retinal (ATR) (via a slow release pellet) to increase tissue photosensitivity in transgenic mice expressing channelrhodopsin 2 (ChR2) in nerves. Main results. In mice supplemented with ATR, we demonstrate enhanced electrophysiological activation and fatigue tolerance in response to optical stimulation for six weeks. Significance. Local supplementation of ATR enables improved optogenetic stimulation efficacy in peripheral nerves. This method enables greater exploration of neurophysiology and development of clinically-viable optogenetic treatments in the peripheral nervous system.
MIT Department
Massachusetts Institute of Technology. Center for Extreme Bionics
Harvard University--MIT Division of Health Sciences and Technology
Terms of Use
Creative Commons Attribution-NonCommercial-NoDerivs License
http://creativecommons.org/licenses/by-nc-nd/3.0/
Persistent DSpace Link
https://hdl.handle.net/1721.1/136221
DOI of Published Version
https://doi.org/10.1088/1741-2552/ab1e22
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.